OncoPharm

Latest Episodes:

Duvelisib Sep 26, 2018

Show notes

The latest #oncopharm approval for duvelisib is discussed as well as the similarities and differences to other PI3K inhibitors previously approved.

The Pseudomonas Exotoxin Drug Sep 20, 2018

Show notes

Discussing the new pseudomonas exotoxin drug (moxetumomab pasudotox-tdfk) for Hairy Cell Leukemia (3rd line). Lots of supportive care measures required, surprisingly, for the pseudomonas exotoxin drug.

*Bonus Pod* World Marrow Donor Day '18 Sep 15, 2018

Show notes

Celebrating World Marrow Donor Day by recapping the HSCT donation experience of your favorite podcast host.

5-Fluorouracil Sep 14, 2018

Show notes

5-FU: both its mechanisms, all its toxicities, most of its uses, and some of its history are discussed.

Ask OncoPharm (Part 1) & RELEVANCE Sep 06, 2018

Show notes

The debut of our mailbag (Ask OncoPharm) to give some tips to new oncology pharmacists. Then (13:10) we review the RELEVANCE study of rituximab/lenalidomide in follicular lymphoma.

Influenza Vaccination during Chemo Aug 30, 2018

Show notes

It's flu shot season, so we're taking a pseudo-systematic review of influenza vaccination in patient receiving chemotherapy. Questions addressed include: How effective is influenza vaccination for cancer patients? What's the optimal timing of vaccination during chemo?

Small Cell Lung Cancer: Established & Recent Advances Aug 23, 2018

Show notes

Small cell lung cancer is reviewed, including the milestone advances (chemo + RT, omitting surgery, cis/etoposide) of the past leading up to the latest advance (15:20) - FDA-approval of nivolumab in the 3rd-line setting.

Mogamulizumab & August updates Aug 16, 2018

Show notes

Mogamulizumab-kpkc (MOAs, administration, toxicity) and its FDA-approval is discussed followed by (9:00) updates lenvatinib (a good update) and azithromycin (a bad update) in cancer patients.

Rituximab Aug 09, 2018

Show notes

We explore the origins of rituximab's dose, geek out on the NNT in DLBC, and discuss other "need to know" tidbits.

Iobenguane I-131 & Lusutrombopag Aug 02, 2018

Show notes

Catching up the recent FDA-approvals for iobenguane I-131 (and its myriad of precautions) and lusutrombopag.